BRPI0913297A2 - composição, farmacêutica, uso de uma composição, e, kit terapêutico. - Google Patents
composição, farmacêutica, uso de uma composição, e, kit terapêutico.Info
- Publication number
- BRPI0913297A2 BRPI0913297A2 BRPI0913297A BRPI0913297A BRPI0913297A2 BR PI0913297 A2 BRPI0913297 A2 BR PI0913297A2 BR PI0913297 A BRPI0913297 A BR PI0913297A BR PI0913297 A BRPI0913297 A BR PI0913297A BR PI0913297 A2 BRPI0913297 A2 BR PI0913297A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- pharmaceutical
- therapeutic kit
- kit
- therapeutic
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5794008P | 2008-06-02 | 2008-06-02 | |
| PCT/EP2009/056751 WO2009147144A2 (en) | 2008-06-02 | 2009-06-02 | Composition comprising an antibiotic and a corticosteroid |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0913297A2 true BRPI0913297A2 (pt) | 2016-01-26 |
| BRPI0913297B1 BRPI0913297B1 (pt) | 2019-01-29 |
| BRPI0913297B8 BRPI0913297B8 (pt) | 2020-09-15 |
Family
ID=41278754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0913297A BRPI0913297B8 (pt) | 2008-06-02 | 2009-06-02 | composição farmacêutica estabilizada |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20100087409A1 (pt) |
| EP (1) | EP2293778B1 (pt) |
| JP (1) | JP5674648B2 (pt) |
| CN (1) | CN102083414B (pt) |
| AR (1) | AR071988A1 (pt) |
| AU (1) | AU2009253956B2 (pt) |
| BR (1) | BRPI0913297B8 (pt) |
| CA (1) | CA2726074C (pt) |
| ES (1) | ES2436193T3 (pt) |
| RU (1) | RU2496501C2 (pt) |
| TW (1) | TW201010708A (pt) |
| WO (1) | WO2009147144A2 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0514098B1 (pt) * | 2004-08-13 | 2021-01-19 | Intervet International B. V. | composição farmacêutica tópica para o tratamento de uma infecção ótica |
| SG190859A1 (en) | 2010-12-20 | 2013-07-31 | Colgate Palmolive Co | Gelatin encapsulated oral care composition containing hydrophilic active, hydrophobic structuring agent and oil carrier |
| EP2502616A1 (fr) * | 2011-03-21 | 2012-09-26 | Matthew Krayenbuhl | Composition pharmaceutique nasale |
| WO2013106230A1 (en) * | 2012-01-10 | 2013-07-18 | Entrx LLC | Otic formulations, methods and devices |
| US9849126B2 (en) | 2013-01-03 | 2017-12-26 | Entrx LLC | Sterile otic formulations |
| MX2018015475A (es) * | 2016-06-13 | 2019-07-12 | Vyome Therapeutics Ltd | Composiciones antifungicas sinérgicas y métodos de las mismas. |
| WO2017216722A2 (en) * | 2016-06-13 | 2017-12-21 | Vyome Biosciences Pvt. Ltd. | Synergistic antifungal compositions and methods thereof |
| WO2025188659A1 (en) * | 2024-03-04 | 2025-09-12 | Ocusoft, Inc. | Medicated eyelid cleansing compositions |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6013711A (ja) * | 1983-06-21 | 1985-01-24 | ザ、プロクタ−、エンド、ギヤンブル、カンパニ− | コルチコステロイドを含有する浸透局所製薬組成物 |
| HUT67445A (en) * | 1991-06-10 | 1995-04-28 | Schering Corp | Aerosol formulations containing 1,1,1,2-tetrafluorethane |
| US7917386B2 (en) * | 1995-06-16 | 2011-03-29 | Catalina Marketing Corporation | Virtual couponing method and apparatus for use with consumer kiosk |
| US5710886A (en) * | 1995-06-16 | 1998-01-20 | Sellectsoft, L.C. | Electric couponing method and apparatus |
| GB9620187D0 (en) * | 1996-09-27 | 1996-11-13 | Minnesota Mining & Mfg | Medicinal aerosol formulations |
| JP2002543776A (ja) * | 1999-05-07 | 2002-12-24 | スミスクライン・ビーチャム・コーポレイション | ａｒｏＡの作用機構を用いる方法 |
| US20080052169A1 (en) * | 2000-03-29 | 2008-02-28 | O'shea Deirdre | Method and apparatus for providing a coupon offer having a variable value |
| RU2201219C2 (ru) * | 2001-04-24 | 2003-03-27 | Макаров Константин Алексеевич | Фармакологическая композиция пролонгированного действия |
| US6589955B2 (en) * | 2001-06-20 | 2003-07-08 | Bristol-Myers Squibb Company | Pediatric formulation of gatifloxacin |
| WO2003025822A1 (en) * | 2001-09-19 | 2003-03-27 | Matsushita Electric Corporation Of America | Adaptive electronic coupon |
| RU2267491C1 (ru) * | 2004-07-14 | 2006-01-10 | Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия") | Физиологически активная композиция, замещенные 1-оксо-1,2-дигидро[2,7]-нафтиридины, способ их получения, применения и набор |
| WO2005044276A1 (ja) * | 2003-11-07 | 2005-05-19 | Senju Pharmaceutical Co., Ltd. | プロスタグランジン含有医薬組成物 |
| US20050118206A1 (en) * | 2003-11-14 | 2005-06-02 | Luk Andrew S. | Surfactant-based gel as an injectable, sustained drug delivery vehicle |
| BRPI0514098B1 (pt) * | 2004-08-13 | 2021-01-19 | Intervet International B. V. | composição farmacêutica tópica para o tratamento de uma infecção ótica |
| US20060041469A1 (en) * | 2004-08-18 | 2006-02-23 | Torrance Mathis | Marketing system employing electronically generated discount coupons |
| WO2007064912A2 (en) * | 2005-12-02 | 2007-06-07 | Elan Pharma International Limited | Mometasone compositions and methods of making and using the same |
| US20070196398A1 (en) * | 2006-02-17 | 2007-08-23 | Murthy Yerramilli V S | Fluoroquinolone fatty acid salt compositions |
| US8268347B1 (en) * | 2006-10-24 | 2012-09-18 | Aradigm Corporation | Dual action, inhaled formulations providing both an immediate and sustained release profile |
| US20080253970A1 (en) * | 2007-02-09 | 2008-10-16 | Schering Corporation | Stable Pharmaceutical Drug Products |
| EP2278957A2 (en) * | 2008-04-15 | 2011-02-02 | Schering Corporation | Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas |
-
2009
- 2009-05-27 TW TW098117771A patent/TW201010708A/zh unknown
- 2009-06-02 RU RU2010154083/15A patent/RU2496501C2/ru active
- 2009-06-02 AU AU2009253956A patent/AU2009253956B2/en active Active
- 2009-06-02 EP EP09757525.2A patent/EP2293778B1/en active Active
- 2009-06-02 CA CA2726074A patent/CA2726074C/en active Active
- 2009-06-02 WO PCT/EP2009/056751 patent/WO2009147144A2/en not_active Ceased
- 2009-06-02 ES ES09757525T patent/ES2436193T3/es active Active
- 2009-06-02 CN CN2009801255946A patent/CN102083414B/zh active Active
- 2009-06-02 US US12/476,783 patent/US20100087409A1/en not_active Abandoned
- 2009-06-02 BR BRPI0913297A patent/BRPI0913297B8/pt active IP Right Grant
- 2009-06-02 JP JP2011512100A patent/JP5674648B2/ja active Active
- 2009-06-02 AR ARP090101978A patent/AR071988A1/es not_active Application Discontinuation
-
2011
- 2011-11-01 US US13/286,747 patent/US10045940B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP5674648B2 (ja) | 2015-02-25 |
| WO2009147144A3 (en) | 2010-09-16 |
| BRPI0913297B8 (pt) | 2020-09-15 |
| HK1156876A1 (en) | 2012-06-22 |
| AR071988A1 (es) | 2010-07-28 |
| RU2010154083A (ru) | 2012-07-20 |
| RU2496501C2 (ru) | 2013-10-27 |
| CN102083414B (zh) | 2013-10-23 |
| EP2293778A2 (en) | 2011-03-16 |
| US10045940B2 (en) | 2018-08-14 |
| AU2009253956B2 (en) | 2016-05-12 |
| TW201010708A (en) | 2010-03-16 |
| EP2293778B1 (en) | 2013-09-18 |
| CA2726074C (en) | 2016-07-19 |
| US20100087409A1 (en) | 2010-04-08 |
| JP2011521999A (ja) | 2011-07-28 |
| US20120046259A1 (en) | 2012-02-23 |
| BRPI0913297B1 (pt) | 2019-01-29 |
| WO2009147144A2 (en) | 2009-12-10 |
| CA2726074A1 (en) | 2009-12-10 |
| CN102083414A (zh) | 2011-06-01 |
| AU2009253956A1 (en) | 2009-12-10 |
| ES2436193T3 (es) | 2013-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0917315A2 (pt) | anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica | |
| BRPI0908792A2 (pt) | Composição, e, uso de uma combinação | |
| BRPI0813770A2 (pt) | Composição, e, uso de uma composição | |
| BRPI0917001A2 (pt) | composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica | |
| BRPI0912717A2 (pt) | Composição farmacêutica, e, uso de 5-azacitidina | |
| BRPI0821115A2 (pt) | Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto | |
| BRPI0919942A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI0907562A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0921375A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0905369A2 (pt) | Composição farmacêutica, composição e kit compartimentado | |
| BRPI0810696A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI0815709A2 (pt) | composro, composição farmacêutica, e, uso de um composto. | |
| BRPI0914793A2 (pt) | Composição, e, uso de uma composição | |
| BRPI0917579A2 (pt) | composto, composição farmacêutica, métodos, e, uso de um composto | |
| BRPI1014316A2 (pt) | composição, e, uso de uma composição | |
| BRPI0905715A2 (pt) | Composição farmacêutica e kit de componentes | |
| BR112012004335A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
| BRPI1013421A2 (pt) | composição parasticida tópica, e, uso de uma composição | |
| BRPI0921879A2 (pt) | composto, composição farmacêutica , e, uso de um composto | |
| BRPI0906253A2 (pt) | Composição de dentifrício, e, uso de uma composição | |
| BRPI1006953A2 (pt) | composição farmacêutica, e, uso de uma composição | |
| BRPI1009392A2 (pt) | "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica." | |
| BRPI0906937A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0810019A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI0812942A2 (pt) | Composto, composição farmacêutica e uso de um composto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/06/2009, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REF. RPI 2508 DE 29/01/2019 QUANTO AO TITULAR E AO ENDERECO. |